NeuroRx seeks emergency use authorization for its experimental Covid-19 therapy

The Wilmington company, which has its clinical operations in Radnor, is developing the therapy in a partnership with a Swiss company.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.